tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:9887 Stock Latest News

Nanjing Leads Biolabs’ Cancer Antibody LBL-024 Wins FDA Fast Track Status for EP-NEC
Company AnnouncementsNanjing Leads Biolabs’ Cancer Antibody LBL-024 Wins FDA Fast Track Status for EP-NEC
4d ago
9887
Nanjing Leads Biolabs Sets Up Audit Committee to Strengthen Corporate Governance
PremiumCompany Announcements
Nanjing Leads Biolabs Sets Up Audit Committee to Strengthen Corporate Governance
19d ago
9887
Nanjing Leads Biolabs Sets Formal Rules for Board Remuneration Committee
PremiumCompany Announcements
Nanjing Leads Biolabs Sets Formal Rules for Board Remuneration Committee
19d ago
9887
Nanjing Leads Biolabs Sets Up Nomination Committee to Tighten Governance and Board Selection
PremiumCompany Announcements
Nanjing Leads Biolabs Sets Up Nomination Committee to Tighten Governance and Board Selection
19d ago
9887
Nanjing Leads Biolabs Doses First Patient in Phase Ib/II Trial of LBL-024 for Platinum-Resistant Ovarian Cancer
PremiumCompany Announcements
Nanjing Leads Biolabs Doses First Patient in Phase Ib/II Trial of LBL-024 for Platinum-Resistant Ovarian Cancer
26d ago
9887
Nanjing Leads Biolabs Doses First Subject in Phase I Trial of Autoimmune Drug LBL-047
PremiumCompany AnnouncementsNanjing Leads Biolabs Doses First Subject in Phase I Trial of Autoimmune Drug LBL-047
27d ago
9887
Nanjing Leads Biolabs Streamlines Governance and Introduces H Share Award Scheme
Premium
Company Announcements
Nanjing Leads Biolabs Streamlines Governance and Introduces H Share Award Scheme
1M ago
9887
Nanjing Leads Biolabs Announces H Share Full Circulation Initiative
Premium
Company Announcements
Nanjing Leads Biolabs Announces H Share Full Circulation Initiative
1M ago
9887
Nanjing Leads Biolabs Showcases Promising LBL-034 Data at ASH Meeting
PremiumCompany Announcements
Nanjing Leads Biolabs Showcases Promising LBL-034 Data at ASH Meeting
1M ago
9887
Nanjing Leads Biolabs’ LBL-047 Receives IND Approval, Partners with Dianthus Therapeutics
PremiumCompany Announcements
Nanjing Leads Biolabs’ LBL-047 Receives IND Approval, Partners with Dianthus Therapeutics
2M ago
9887
Nanjing Leads Biolabs Announces Extraordinary General Meeting to Discuss Key Resolutions
PremiumCompany Announcements
Nanjing Leads Biolabs Announces Extraordinary General Meeting to Discuss Key Resolutions
2M ago
9887
Nanjing Leads Biolabs Announces Book Closure for Upcoming EGM
PremiumCompany Announcements
Nanjing Leads Biolabs Announces Book Closure for Upcoming EGM
2M ago
9887
Nanjing Leads Biolabs Proposes H Share Award Scheme and Governance Changes
PremiumCompany AnnouncementsNanjing Leads Biolabs Proposes H Share Award Scheme and Governance Changes
2M ago
9887
Nanjing Leads Biolabs Advances Phase II Trial for Cancer Treatment
Premium
Company Announcements
Nanjing Leads Biolabs Advances Phase II Trial for Cancer Treatment
2M ago
9887
Nanjing Leads Biolabs Joins MSCI Global Small Cap Indexes
Premium
Company Announcements
Nanjing Leads Biolabs Joins MSCI Global Small Cap Indexes
2M ago
9887
Nanjing Leads Biolabs to Present Key Research at ASH Annual Meeting
PremiumCompany Announcements
Nanjing Leads Biolabs to Present Key Research at ASH Annual Meeting
3M ago
9887
Nanjing Leads Biolabs Advances Cancer Treatment with Phase II Trial of Opamtistomig
PremiumCompany Announcements
Nanjing Leads Biolabs Advances Cancer Treatment with Phase II Trial of Opamtistomig
3M ago
9887
Nanjing Leads Biolabs Clarifies License Agreement Details
PremiumCompany Announcements
Nanjing Leads Biolabs Clarifies License Agreement Details
3M ago
9887
Nanjing Leads Biolabs Partners with Dianthus for Global Advancement of LBL-047
PremiumCompany Announcements
Nanjing Leads Biolabs Partners with Dianthus for Global Advancement of LBL-047
3M ago
9887
Nanjing Leads Biolabs Partners with Dianthus for Global Advancement of LBL-047
PremiumCompany AnnouncementsNanjing Leads Biolabs Partners with Dianthus for Global Advancement of LBL-047
3M ago
9887
Nanjing Leads Biolabs’ Innovative Drug Research Recognized at ASH Annual Meeting
Premium
Company Announcements
Nanjing Leads Biolabs’ Innovative Drug Research Recognized at ASH Annual Meeting
3M ago
9887
Nanjing Leads Biolabs Gains FDA Approval for Novel Autoimmune Drug
Premium
Company Announcements
Nanjing Leads Biolabs Gains FDA Approval for Novel Autoimmune Drug
4M ago
9887

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >